Literature DB >> 6779312

Effects of d-amphetamine and naloxone on brain stimulation reward.

R U Esposito, W Perry, C Kornetsky.   

Abstract

Self-stimulation thresholds were determined in rats by means of a modification of the psychophysical method of limits. Reinforcement values were determined after the administration of d-amphetamine alone, naloxone alone, and naloxone administered concurrently with d-amphetamine. d-Amphetamine yielded dose-related decreases in the threshold (0.25--2.00 mg/kg IP), while naloxone alone (2.0--16 mg/kg IP) caused no consistent changes. For each animal, a dose of d-amphetamine that substantially lowered the threshold was then selected to be administered with varying doses of naloxone. The threshold-lowering effect of d-amphetamine was blocked by naloxone at doses as low as 2.0 or 4.0 mg/kg. This finding suggests the possible involvement of an opiate receptor in the mediation of the enhancement by d-amphetamine of brain stimulation reward.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6779312     DOI: 10.1007/bf00427648

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Effects and interactions of imipramine, chlorpromazine, reserpine and amphetamine on self-stimulation: possible neurophysiological basis of depression.

Authors:  L STEIN
Journal:  Recent Adv Biol Psychiatry       Date:  1961

2.  Apparent independence of opiate reinforcement and electrical self-stimulation systems in rat brain.

Authors:  D van der Kooy; F G LePiane; A G Phillips
Journal:  Life Sci       Date:  1977-03-15       Impact factor: 5.037

3.  Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone.

Authors:  G Biggio; M Casu; M G Corda; C Di Bello; G L Gessa
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

Review 4.  Endorphins and endorphin receptors in striatum: relationships with dopaminergic neurons.

Authors:  J C Schwartz; H Pollard; C Llorens; B Malfroy; C Gros; P Pradelles; F Dray
Journal:  Adv Biochem Psychopharmacol       Date:  1978

5.  Effects of D-amphetamine on concurrent self-stimulation of forebrain and brain stem loci.

Authors:  G F Koob; G D Winger; J L Meyerhoff; Z Annau
Journal:  Brain Res       Date:  1977-11-25       Impact factor: 3.252

6.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

7.  Lithium and amphetamine: opposite effects on threshold of intracranial reinforcement.

Authors:  G P Cassens; A W Mills
Journal:  Psychopharmacologia       Date:  1973-06-19

8.  The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex.

Authors:  A G Phillips; H C Fibiger
Journal:  Can J Psychol       Date:  1978-06

9.  Naloxone blocks the excitatory effect of ethanol and chlordiazepoxide on lateral hypothalamic self-stimulation behavior.

Authors:  S A Lorens; S M Sainati
Journal:  Life Sci       Date:  1978-10-02       Impact factor: 5.037

10.  Amphetamine, chlorpromazine and clonidine effects on self-stimulation in caudate or hypothalamus of the squirrel monkey.

Authors:  J Spencer; A Revzin
Journal:  Pharmacol Biochem Behav       Date:  1976-08       Impact factor: 3.533

View more
  28 in total

1.  Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of D-amphetamine.

Authors:  Marta Valenza; Luca Steardo; Pietro Cottone; Valentina Sabino
Journal:  Psychopharmacology (Berl)       Date:  2015-06-07       Impact factor: 4.530

2.  The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats.

Authors:  Clayton T Bauer; Matthew L Banks; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

Review 3.  Agonist Medications for the Treatment of Cocaine Use Disorder.

Authors:  S Stevens Negus; Jack Henningfield
Journal:  Neuropsychopharmacology       Date:  2014-12-11       Impact factor: 7.853

Review 4.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

5.  Effects of low-level microwave irradiation on amphetamine hyperthermia are blockable by naloxone and classically conditionable.

Authors:  H Lai; A Horita; C K Chou; A W Guy
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions.

Authors:  M Eghbali; C Santoro; W Paredes; E L Gardner; R S Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.

Authors:  Azin Behnood-Rod; Ranjithkumar Chellian; Ryann Wilson; Takato Hiranita; Abhisheak Sharma; Francisco Leon; Christopher R McCurdy; Lance R McMahon; Adriaan W Bruijnzeel
Journal:  Drug Alcohol Depend       Date:  2020-08-18       Impact factor: 4.492

8.  Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.

Authors:  Yan Zhang; Amanda Braithwaite; Yunyun Yuan; John M Streicher; Edward J Bilsky
Journal:  Eur J Pharmacol       Date:  2014-05-08       Impact factor: 4.432

9.  Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation.

Authors:  L van Wolfswinkel; J M van Ree
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

10.  Role of µ-opioid receptor reserve and µ-agonist efficacy as determinants of the effects of µ-agonists on intracranial self-stimulation in rats.

Authors:  Ahmad A Altarifi; Laurence L Miller; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2012-10       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.